| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1830 | 2020 |
| PD-L1 as a biomarker of response to immune-checkpoint inhibitors DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ... Nature reviews Clinical oncology 18 (6), 345-362, 2021 | 811 | 2021 |
| Immunotherapy in non–small cell lung cancer: facts and hopes DB Doroshow, MF Sanmamed, K Hastings, K Politi, DL Rimm, L Chen, ... Clinical Cancer Research 25 (15), 4592-4602, 2019 | 537 | 2019 |
| BET inhibitors: a novel epigenetic approach DB Doroshow, JP Eder, PM LoRusso Annals of Oncology 28 (8), 1776-1787, 2017 | 349 | 2017 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 287 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 170 | 2021 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 142 | 2020 |
| Treatment of advanced non–small cell lung cancer in 2018 DB Doroshow, RS Herbst JAMA oncology 4 (4), 569-570, 2018 | 112 | 2018 |
| Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial TU Marron, MI Fiel, P Hamon, N Fiaschi, E Kim, SC Ward, Z Zhao, J Kim, ... The Lancet Gastroenterology & Hepatology 7 (3), 219-229, 2022 | 102 | 2022 |
| Performing a cure for schizophrenia: insulin coma therapy on the wards DB Doroshow Journal of the history of medicine and allied sciences 62 (2), 213-243, 2007 | 78 | 2007 |
| Cancer care disparities during the COVID-19 pandemic: COVID-19 and cancer outcomes study AL Schmidt, Z Bakouny, S Bhalla, JA Steinharter, DA Tremblay, MM Awad, ... Cancer cell 38 (6), 769-770, 2020 | 63 | 2020 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 55 | 2020 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 47 | 2022 |
| Survey of the impact of COVID-19 on oncologists’ decision making in cancer Y Ürün, SA Hussain, Z Bakouny, D Castellano, S Kılıçkap, G Morgan, ... JCO global oncology 6, 1248-1257, 2020 | 47 | 2020 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 40 | 2021 |
| Ceralasertib-mediated ATR inhibition combined with olaparib in advanced cancers harboring DNA damage response and repair alterations (olaparib combinations) H Mahdi, N Hafez, D Doroshow, D Sohal, V Keedy, KT Do, P LoRusso, ... JCO Precision Oncology 5, 1432-1442, 2021 | 40 | 2021 |
| Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study S Pant, M Schuler, G Iyer, O Witt, T Doi, S Qin, J Tabernero, DA Reardon, ... The Lancet Oncology 24 (8), 925-935, 2023 | 35 | 2023 |
| Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19). JL Warner, S Rubinstein, P Grivas, TK Choueiri, NM Kuderer, D Shah, ... Journal of Clinical Oncology 38 (18_suppl), LBA110-LBA110, 2020 | 34 | 2020 |
| Genomics and the history of precision oncology DB Doroshow, JH Doroshow Surgical Oncology Clinics 29 (1), 35-49, 2020 | 31 | 2020 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 30 | 2023 |
